homevideos Newshealthcare News

Zydus focusing on top 30 molecules; expects double digit growth for India, says MD Sharvil Patel

videos | Mar 23, 2022 4:28 PM IST

Zydus focusing on top 30 molecules; expects double-digit growth for India, says MD Sharvil Patel

Mini

Zydus Lifesciences is focussing on top 30 molecules, said Sharvil Patel, managing director, on Wednesday, adding that the company expects double-digit growth for India.

Zydus Lifesciences is focussing on top 30 molecules, said Sharvil Patel, managing director, on Wednesday, adding that the company expects double-digit growth for India.

Recommended Articles

View All

In an interview to CNBC-TV18, he said, “At the stage, we are at now with a focus on the top 30 molecules with the new introductions on the proprietary molecule side, we are poised to deliver better than market growth and double-digit growth for India formulations business and we are confident of doing so.”
Talking about US business, he said that it has always been a cyclical business and it should be seen in a 3-5 year window. “We believe that any good company with a strong portfolio, good cost, position, good backward integration can continue to do well in the US generics markets,” said Patel.
He further said that the company expects generic launches in the next 18 months to aid US business and it should scale up to USD 1 billion revenue range through these launches.
For more details, watch the accompanying video
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!

Top Budget Opinions

    Most Read

    Market Movers

    View All
    Top GainersTop Losers
    CurrencyCommodities
    CompanyPriceChng%Chng